Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Prostate Cancer

 

Free Subscription


11.06.2008

1 BMC Cancer
2 Cancer
3 Cancer Res
4 Clin Cancer Res
10 Eur Urol
2 Int J Cancer
1 Int J Oncol
7 Int J Radiat Oncol Biol Phys
1 J Nucl Med
7 J Urol
6 Prostate
1 Radiology
4 Urol Int
3 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. HIDALGO M , Galan JJ, Saez C, Ferrero E, et al
    Methylation alterations are not a major cause of PTTG1 misregulation.
    BMC Cancer. 2008;8:110.
    PubMed     Related articles    Abstract available   Free Full Text


    Cancer

  2. WEIGHT CJ , Klein EA, Jones JS
    Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
    Cancer. 2008;112:2195-201.
    PubMed     Related articles    Abstract available

  3. SCHWARTZ MJ , Hwang DH, Hung AJ, Han J, et al
    Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy.
    Cancer. 2008;112:1718-25.
    PubMed     Related articles    Abstract available


    Cancer Res

  4. MONTGOMERY RB , Mostaghel EA, Vessella R, Hess DL, et al
    Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
    Cancer Res. 2008;68:4447-54.
    PubMed     Related articles    Abstract available

  5. LIN D , Watahiki A, Bayani J, Zhang F, et al
    ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
    Cancer Res. 2008;68:4352-9.
    PubMed     Related articles    Abstract available

  6. CAMORIANO M , Kinney SR, Moser MT, Foster BA, et al
    Phenotype-specific CpG island methylation events in a murine model of prostate cancer.
    Cancer Res. 2008;68:4173-82.
    PubMed     Related articles    Abstract available


    Clin Cancer Res

  7. MYRTHUE A , Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, et al
    The Iroquois Homeobox Gene 5 Is Regulated by 1,25-Dihydroxyvitamin D3 in Human Prostate Cancer and Regulates Apoptosis and the Cell Cycle in LNCaP Prostate Cancer Cells.
    Clin Cancer Res. 2008;14:3562-70.
    PubMed     Related articles    Abstract available

  8. TEIXEIRA AL , Ribeiro R, Cardoso D, Pinto D, et al
    Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients.
    Clin Cancer Res. 2008;14:3367-71.
    PubMed     Related articles    Abstract available

  9. RAVEL D , Dubois V, Quinonero J, Meyer-Losic F, et al
    Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin.
    Clin Cancer Res. 2008;14:1258-65.
    PubMed     Related articles    Abstract available

  10. HAHM ER , Arlotti JA, Marynowski SW, Singh SV, et al
    Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Clin Cancer Res. 2008;14:1248-57.
    PubMed     Related articles    Abstract available


    Eur Urol

  11. HEIDENREICH A
    Management of Advanced Prostate Cancer: Gonadotropin-Releasing Hormone Blockers Might Improve Prognosis.
    Eur Urol. 2008;.
    PubMed     Related articles   

  12. YARDY GW , Bicknell DC, Wilding JL, Bartlett S, et al
    Mutations in the AXIN1 Gene in Advanced Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available

  13. SCHALKEN JA
    Editorial Comment on: Mutations in the AXIN1 Gene in Advanced Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   

  14. VICKERS AJ
    Editorial Comment on: Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   

  15. BRIGANTI A , Capitanio U, Chun FK, Gallina A, et al
    Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available

  16. SHARIAT SF
    Editorial Comment on: Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer.
    Eur Urol. 2008;.
    PubMed     Related articles   

  17. CAPITANIO U , Karakiewicz PI, Jeldres C, Briganti A, et al
    Suspected Clinical T3 Prostate Cancer Is Associated with a High Rate of Negative Extended Biopsies: Clinical Implications.
    Eur Urol. 2008;.
    PubMed     Related articles   

  18. BRIGANTI A , Chun FK, Karakiewicz PI, Rigatti P, et al
    Is Node-Positive Prostate Cancer Always a Systemic Disease?
    Eur Urol. 2008;.
    PubMed     Related articles   

  19. PELZER AE
    Re: under diagnosis and over diagnosis of prostate cancer.
    Eur Urol. 2008;54:234-5.
    PubMed     Related articles   

  20. MOUL JW
    Re: Obesity-Related Plasma Hemodilution and PSA Concentration Among Men with Prostate Cancer.
    Eur Urol. 2008;54:232-3.
    PubMed     Related articles   


    Int J Cancer

  21. ZHANG H , Zhang Y, Duan HO, Kirley SD, et al
    TIP30 is associated with progression and metastasis of prostate cancer.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available

  22. PARK SY , Murphy SP, Wilkens LR, Henderson BE, et al
    Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available


    Int J Oncol

  23. PULUKURI SM , Rao JS
    Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis.
    Int J Oncol. 2008;32:757-65.
    PubMed     Related articles    Abstract available


    Int J Radiat Oncol Biol Phys

  24. OTON CA , Oton F
    Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to stone et Al. (Int j radiat oncol biol phys 2007;69:1472-1477).
    Int J Radiat Oncol Biol Phys. 2008;71:962.
    PubMed     Related articles   

  25. LANGSENLEHNER T , Kapp KS, Langsenlehner U
    TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to peters et Al. (Int j radiat oncol biol phys 2008;70:752-759).
    Int J Radiat Oncol Biol Phys. 2008;71:960.
    PubMed     Related articles   

  26. FULLER DB , Naitoh J, Lee C, Hardy S, et al
    Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Int J Radiat Oncol Biol Phys. 2008;70:1588-97.
    PubMed     Related articles    Abstract available

  27. SHAH AP , Langen KM, Ruchala KJ, Cox A, et al
    Patient dose from megavoltage computed tomography imaging.
    Int J Radiat Oncol Biol Phys. 2008;70:1579-87.
    PubMed     Related articles    Abstract available

  28. RUBEN JD , Davis S, Evans C, Jones P, et al
    The effect of intensity-modulated radiotherapy on radiation-induced second malignancies.
    Int J Radiat Oncol Biol Phys. 2008;70:1530-6.
    PubMed     Related articles    Abstract available

  29. D'AMBROSIO DJ , Ruth K, Horwitz EM, Uzzo RG, et al
    How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?
    Int J Radiat Oncol Biol Phys. 2008;70:1487-91.
    PubMed     Related articles    Abstract available

  30. KING CR , Presti JC, Brooks JD, Gill H, et al
    Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
    Int J Radiat Oncol Biol Phys. 2008;70:1472-7.
    PubMed     Related articles    Abstract available


    J Nucl Med

  31. MULLANI NA , Herbst RS, O'Neil RG, Gould KL, et al
    Tumor Blood Flow Measured by PET Dynamic Imaging of First-Pass 18F-FDG Uptake: A Comparison with 15O-Labeled Water-Measured Blood Flow.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available


    J Urol

  32. SHAPIRO E , Huang H, Ruoff R, Lee P, et al
    The heterochromatin protein 1 family is regulated in prostate development and cancer.
    J Urol. 2008;179:2435-9.
    PubMed     Related articles    Abstract available

  33. SMITH ND , Schulze-Hoepfner FT, Veliceasa D, Filleur S, et al
    Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.
    J Urol. 2008;179:2427-34.
    PubMed     Related articles    Abstract available

  34. ARLEN PM , Bianco F, Dahut WL, D'Amico A, et al
    Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
    J Urol. 2008;179:2181-5.
    PubMed     Related articles    Abstract available

  35. YOON GS , Wang W, Osunkoya AO, Lane Z, et al
    Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.
    J Urol. 2008;179:2203-6.
    PubMed     Related articles    Abstract available

  36. KOCH MO
    Focal prostate therapy.
    J Urol. 2008;179:2091.
    PubMed     Related articles   

  37. KLEIN EA , Bianco FJ, Serio AM, Eastham JA, et al
    Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
    J Urol. 2008;179:2212-6.
    PubMed     Related articles    Abstract available

  38. EASTHAM JA , Scardino PT, Kattan MW
    Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
    J Urol. 2008;179:2207-10.
    PubMed     Related articles    Abstract available


    Prostate

  39. HAYASHI N , Koller E, Fazli L, Gleave ME, et al
    Effects of Eg5 knockdown on human prostate cancer xenograft growth and chemosensitivity.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available

  40. KIM MH , Field J
    Translationally regulated C/EBPbeta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available

  41. LAI TH , Fong YC, Fu WM, Yang RS, et al
    Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available

  42. PETERNAC D , Klima I, Cecchini MG, Schwaninger R, et al
    Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available

  43. MARUYAMA-TAKAHASHI K , Shimada N, Imada T, Maekawa-Tokuda Y, et al
    A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
    Prostate. 2008;68:640-50.
    PubMed     Related articles    Abstract available

  44. TSUI KH , Hsieh WC, Lin MH, Chang PL, et al
    Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Prostate. 2008;68:610-9.
    PubMed     Related articles    Abstract available


    Radiology

  45. MUNTENER M , Patriciu A, Petrisor D, Schar M, et al
    Transperineal prostate intervention: robot for fully automated MR imaging--system description and proof of principle in a canine model.
    Radiology. 2008;247:543-9.
    PubMed     Related articles    Abstract available


    Urol Int

  46. SCIARRA A , Gentile V, De Matteis A, Dattilo C, et al
    Long-term experience with an anatomical anterograde approach to radical prostatectomy: results in terms of positive margin rate.
    Urol Int. 2008;80:151-6.
    PubMed     Related articles    Abstract available

  47. SCIARRA A , Autran Gomez A, Salciccia S, Dattilo C, et al
    Biopsy-derived Gleason artifact and prostate volume: experience using ten samples in larger prostates.
    Urol Int. 2008;80:145-50.
    PubMed     Related articles    Abstract available

  48. SCIARRA A , Gentile V, Monti S, Dattilo C, et al
    Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia.
    Urol Int. 2008;80:68-73.
    PubMed     Related articles    Abstract available

  49. BRIERLY RD , O'Brien TS
    The importance of palliative care in urology.
    Urol Int. 2008;80:13-8.
    PubMed     Related articles    Abstract available


    Urology

  50. GILBERT SM , Dunn RL, Miller DC, Daignault S, et al
    Mortality after urologic cancer surgery: impact of non-index case volume.
    Urology. 2008;71:906-10.
    PubMed     Related articles    Abstract available

  51. EPSTEIN JI
    Is radical prostatectomy tumor volume an independent predictor of prognosis in men with favorable preoperative clinical and pathologic findings.
    Urology. 2008;71:985.
    PubMed     Related articles   

  52. DI SILVERIO F , Sciarra A, Gentile V
    Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomy.
    Urology. 2008;71:947-51.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: